Allscripts Healthcare Solutions
(
MDRX
), a leading player in the health care information technology
(HCIT) market, recently reported that Coordinated Health, an
integrated health delivery chain operating in New Jersey and
Pennsylvania, has selected Allscripts Sunrise Clinical Manager as
the Electronic Health Record (EHR) of choice.
This EHR will facilitate joint care efforts across Coordinated
Health's multiple locations. Furthermore, it will provide medical
practitioners timely access to patient-related data.
Coordinated Health utilizes Allscripts Enterprise offerings for its
outpatient EHR requirements. It will now use the Allscripts Sunrise
Clinical Manager to convert inpatient records into an electronic
mode. Allscripts will ensure a composite and unified electronic
data solution across their medical
practice.
Coordinated Health has multiple locations in the eastern part of
Pennsylvania. It has specialists in different practices, such as
cardiology and orthopedics.
The health care information technology market is competitive and
price sensitive. Among others, Allscripts faces strong competition
from
Cerner Corp.
(
CERN
),
Quality Systems
(
QSII
) and
Athenahealth
(
ATHN
).
However, optimism about the growth prospects of select HCIT service
providers remains high under the Obama administration, which passed
a Stimulus package in 2009. Part of the Stimulus package is aimed
at increasing the use of EHR systems by medical practitioners.
While greenfield opportunities are currently shrinking, the
replacement market is growing.
The company has widened its user base after its mergers with Misys
and Eclipsys and increased cross-selling opportunities. We believe
that Allscripts is well positioned in the fast growing business of
selling EHR to physician practices as well as inpatient settings.
We are of the opinion that acute and ambulatory care will continue
to converge in future. Also, that Allscripts is positioned to
provide integrated clinical applications for health care providers
to satisfy HITECH Act requirements and eventually comply with an
outcomes-based reimbursement system.
We have a long-term Neutral recommendation on Allscripts. The stock
currently retains a Zacks #2 Rank, which translates into a
short-term Buy rating.
ATHENAHEALTH IN (ATHN): Free Stock Analysis
Report
CERNER CORP (CERN): Free Stock Analysis Report
ALLSCRIPTS HLTH (MDRX): Free Stock Analysis
Report
QUALITY SYS (QSII): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment
Research